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Abstract
Background: A definition of myocardial infarction with non-obstructive coronary arteries (MINOCA) was 
published by European Society of Cardiology in 2016. The aim of this study is to analyze the clinical profile 
and prognosis of these patients in a prospective single-center study and compare it with the literature data.
Methods: During a 3-year period, information from every consecutive MINOCA patient was gathered 
(n = 109). It was then compared with 412 contemporaneous patients with myocardial infarction and 
obstructive coronary arteries (MIOCA). Univariate and multivariate analyses were performed. Prog-
nosis analysis was adjusted by age and cardiovascular risk factors (CVRF).
Results: MINOCA represented 16.9% of the total of patients admitted for myocardial infarction (MI). 
Compared with MIOCA, they had more psychosocial disorders (22.9% vs. 10.7%; p < 0.01) and more 
pro-inflammatory conditions (34.9% vs. 14.0%; p < 0.01). Atrial fibrillation was twice as frequent in 
MINOCA (14.7% vs. 7.3%; p = 0.016). Predictors of MINOCA were as follows: female gender, absence 
of diabetes, absence of tobacco use, tachycardia, troponin above 10 times the 99th percentile, and pro-
inflammatory conditions. Median follow-up was 17.3 ± 9.3 months. Major adverse cardiovascular 
events (MACE; a composite of a recurrence of acute MI, transient ischemic attack/stroke, or death from 
cardiovascular cause and death from any cause) occurred in 10.8% of the MINOCA group as compared 
with 10.7% in the MIOCA group (hazard ratio [HR] 1.19, 95% confidence interval [CI] 0.58–2.45;  
p = 0.645). Cardiovascular re-admission rates were higher in the MINOCA group: 19.8% vs. 13.9% 
(HR 1.85; CI 1.06–3.21; p = 0.030).
Conclusions: The frequency of MINOCA is high, with fewer CVRF, and it is linked to atrial fibril-
lation, psychosocial disorders, and pro-inflammatory conditions. Mid-term prognosis is worse than 
previously thought, with a similar proportion of MACE as compared to MIOCA, and even a higher rate 
of cardiovascular re-admissions. (Cardiol J)
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Coronary atherosclerosis and its complications 
play a crucial role [1] in the majority of acute coro-
nary syndromes. Nevertheless, there is a subgroup 
of patients with acute myocardial infarction (AMI) 
in which coronariography shows non-obstructive 
coronary arteries. These patients are denominated 
under the acronym of MINOCA (myocardial infarc-
tion with non-obstructive coronary arteries). In 
extensive epidemiological studies, they represent 
between 5% and 14% of all AMIs [2–6]. This entity 
affects younger patients with fewer cardiovascular 
risk factors (CVRF), mainly women [3, 6, 7], and in 
some cases these were related with psychosocial 
disorders [8, 9]. Its prognosis remains controversial 
[2–5, 10–14], as well as its optimal treatment [4, 5, 
8, 15]. The only solid recommendation is to treat 
the specific physiopathological mechanism when 
it can be identified. Clinical conditions predict-
ing major adverse cardiovascular events (MACE, 
a composite of a recurrence of AMI, transient 
ischemic attack [TIA]/stroke, or death from car-
diovascular cause and death from any cause) and 
mortality of MINOCA patients are similar to those 
already known in patients with AMI and obstructive 
coronary arteries [16].
In daily practice, MINOCA remains a chal-
lenge, with low use of evidence-based medicines [5] 
due to lack of clear information. The main reason 
for this is the absence of a standard definition, 
making comparison between the studies impos-
sible [2, 3, 11, 12] due to the heterogeneity of 
the inclusion criteria [5, 10, 16, 17]. In 2016 the 
European Society of Cardiology (ESC) published 
a Position Paper on MINOCA [4]. It defined it 
as a “working diagnosis” to start searching the 
underlying mechanism in each patient. The ESC 
has clearly and precisely established the criteria 
for classifying a patient as a MINOCA, which is 
a remarkable step in this field. This definition is 
the one used in recent ESC guidelines [18] and 
consensus documents, including the 4th Universal 
Definition of Myocardial Infarction [19].
The aim of this prospective single-center 
study is to analyze the clinical profile, predictors, 
and prognosis of MINOCA based on the ESC crite-
ria compared to patients with AMI and obstructive 
coronary arteries. 
Methods
A prospective analytical study of cohorts per-
formed in a University General Hospital that covers 
a population of 220,000 inhabitants.
Population of the study
All consecutive patients admitted for AMI 
during a 3-year period (from 1st January 2016 to 
31st December 2018) were recorded (Fig. 1). Two 
cohorts were made: one with those who fulfilled 
the MINOCA criteria (Table 1) and the other one 
with the remaining AMI patients. MINOCA was 
defined according to the ESC Position Paper on 
MINOCA [4]: AMI according to the 3rd Universal 
Definition of Myocardial Infarction (which equals 
to type 1 MI in the 4th Universal Definition of Myo-
cardial Infarction) [19, 20]; and coronary arteries 
without significant angiographic obstruction 
(less than < 50% of stenosis). In addition to this, 
there could not be any other obvious explanation 
for the event at the moment of its presentation. 
Figure 1. Formation of the cohorts; MINOCA — myocardial infarction with non-obstructive coronary arteries; MIOCA 
— myocardial infarction with obstructive coronary arteries; ESC — European Society of Cardiology.
4 refused to participate
11 refused to participate
109 consecutive MINOCA 412 consecutive MIOCA
MINOCA MIOCA
rd17 excluded for not fullling the 3  criteria of
ESC denition for MINOCA: abscense of an
obvious explanation for the event at the moment
of its presentation (8 patients with myocarditis, 
4 with obstructive hypertrophic cardiomyopathy
and 2 severe aortic stenosis)
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This point was confirmed in every case during 
a thorough review carried out by trained cardiolo-
gists. Patients who suited the new definition of 
myocardial injury [19] were excluded.
As a control group, we used the second cohort 
consisting of 412 consecutive patients admit-
ted with AMI and obstructive coronary arteries 
(MIOCA) during the same period. 
Based on previous data, around 10% of AMI 
patients will be MINOCA. Above 400 patients will 
be sufficient if we assume a rate of events in the 
first year of 13% in MIOCA and 5% in MINOCA 
(alpha error of 0.05 and power of 0.80).
All patients provided written informed con-
sent. The study was approved by the institutional 
review board and followed the tenets of the Dec-
laration of Helsinki.
Variables
Standardized forms were used to set up the 
database, including demographic information, epi-
demiological data, and relevant clinical information. 
Socio-economic aspects that could act as emotional 
stress modulators were also registered, as well as 
psychosocial disorders (a compound of previously 
dia gnosed psychiatric disease {According to Diagnos-
tic and Statistical Manual of Mental Disorders, fifth 
edition, [21]} and/or chronic anxiety treatment) and 
migraine. Data involving pro-inflammatory conditions 
were also collected: the presence of active cancer, 
autoimmune diseases, or the fact that AMI was an 
intercurrent complication during hospitalization for an-
other pathology. The main laboratory results (Siemens 
Healthcare Diagnostic, Erlangen, Germany) were peak 
creatinine kinase, troponin T, and C-reactive protein.
According to current guidelines and previ-
ous reports [22], optimal medical treatment at 
discharge was considered when patients simulta-
neously received antiplatelets, statins, and angio-
tensin-converter enzyme inhibitors or angiotensin 
receptor blockers.
All in-hospital complications and death from 
any cause were registered. Follow-up analysis 
included the following: MACE, time to first re-
admission, and death from any cause. Follow-up 
data were based on clinical visits, institutional 
database, or telephone interviews. 
Statistical analysis
Continuous variables are presented as means 
and standard deviations or as medians with inter-
quartile range. Categorical variables are provided 
with percentages. Pearson c2 or Student’s t-test 
and their non-parametric equivalent were used 
depending on the variable type. A two-sided p value 
of less than 0.05 was considered statistically sig-
nificant. Characteristics at admission with a p value 
< 0.01 in the univariable comparison were included 
in a logistic regression model (as a block: enter 
method) to determining the presence of early 
predictors of MINOCA.
Survival analysis with Kaplan-Meier (using 
long-rank) was performed for each follow-up event 
between MINOCAs and AMI-coronary artery dis-
ease. Prognosis analysis was developed with mul-
tiple Cox regression models adjusted depending on 
age and CVRF. Odds ratios and hazard ratios (HR) 
are reported with 95% confidence intervals (CI).
Table 1. Inclusion and exclusion criteria for myo-
cardial infarction with non-obstructive coronary 
arteries (MINOCA) according to European  
Society of Cardiology position paper.
Inclusion criteria
AMI criteria
Positive cardiac biomarker (preferably cardiac  
troponin) defined as a rise and/or fall in serial levels, 
with at least one value above the 99th percentile  
upper reference limit
+
Corroborative clinical evidence of infarction shown 
by at least one of the following: 
 — Symptoms of ischemia
 — New or presumed new significant ST-T changes 
or new LBBB
 — Development of pathological Q waves
 — Imaging evidence of new loss of viable myocar-
dium or new RWMA
 — Intracoronary thrombus evident on angiography  
or at autopsy
Non-obstructive coronary arteries on angiography. 
This includes both patients with: 
 — Normal coronary arteries (no stenosis or < 30%) 
or
 — Mild coronary atheromatosis (stenosis > 30%  
but < 50%)
Exclusion criteria
Alternative cause for the acute presentation
 — Suspected myocarditis at admission
 — Suspected pulmonary thromboembolism
Acute myocardial injury
Elevated troponin value above the 99th percentile 
(with a rise and/or fall of troponin value) but without 
clinical or electrocardiographic evidence of acute 
myocardial ischemia
LBBB — left bundle branch block; RWMA — regional wall motion 
abnormality
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Results
Clinical characteristics  
and in-hospital evolution
During the recruitment period, 644 consecu-
tive patients were diagnosed with AMI. Coro-
nariography was performed in 521 cases. Among 
those, 109 fulfilled the 2016 ESC definition of 
MINOCA, representing 16.9% of the AMI admit-
ted at the hospital. The most common underlying 
mechanism in MINOCA was stress myocardiopathy 
(25.9%). In 13.4% plaque disruption was identified, 
9.8% had positive vasospasm provocation test, 3.6% 
presented coronary emboli, and 0.9% coronary dis-
section. Almost 9% were diagnosed with type 2 AMI. 
In 30.8% the mechanism remained unclear despite all 
tests performed. Only 7.1% of the patients initially 
included in the working diagnosis of MINOCA were 
finally diagnosed with myocarditis.
Considering that this is the sole hospital 
for the sanitary population in the area (totaling 
220,000), we can estimate an annual incidence of 
36.3/MINOCA/year and an annual incidence tax of 
0.17 MINOCA per 1000 inhabitants/year.
Table 2 summarizes baseline characteristics of 
both cohorts. Patients with MINOCA compared to 
those with MIOCA were more frequently women 
(51.4% vs. 21.8%; p < 0.001) and with a better 
cardiovascular risk profile: less diabetes (23.9% vs. 
35.6%; p = 0.020) and lower smoking rates (40.3% 
vs. 65.5%; p < 0.001). Regarding the patients’ age, 
MINOCA patients were non-significantly younger 
(64.6 ± 14.9 years and 66.7 ± 13.5 years, respec-
tively; p = 0.171).
The prevalence of pro-inflammatory conditions 
(compound of autoimmune diseases, active cancer, 
and being AMI a complication intercurrent with 
hospitalization for another pathology) was higher 
in the MINOCA group: 34.9% vs. 14.0%; p < 0.001. 
The relationship was maintained with autoimmune 
diseases (17.4% vs. 8.0%; p < 0.004) and active 
cancer (10.1% vs. 3.4%; p < 0.004) on their own.
The atrial fibrillation rate was twice as fre-
quent in the MINOCA group compared to the 
MIOCA group (14.7% vs. 7.3%; p = 0.016). Psy-
chosocial disorders and migraine were higher in the 
MINOCA group: 22.9% vs. 10.7% (p = 0.001) and 
10.1% vs. 4.1% (p = 0.015), respectively.
The main data regarding hospitalization are 
shown in Table 3. MINOCA patients had higher 
heart rate at presentation (89.2 ± 27.1 vs. 79.1 ± 
± 17.7; p < 0.001). The main symptom was angina 
in 73.9% of MINOCA patients as compared with 
82.8% in the MIOCA group (p = 0.027). MINOCA 
patients less frequently had an ischemic electrocar-
diogram pattern (new or presumed new significant 
ST-T changes or new left bundle branch block; 
61.1% vs. 72.7%; p < 0.020). As Table 2 shows, 
cardiac necrosis biomarkers were lower in the 
MINOCA group. Left ventricular dysfunction was 
present in 33.8% of MINOCA group as compared 
to 31.5% of the MIOCA group (p = 0.659). None of 
the MINOCA patients was revascularized; regard-
ing MIOCA group, 93.9% underwent percutaneous 
coronary intervention and 6.1% had bypass surgery.
In-hospital complications (re-infarction, major 
bleeding, stroke, cardiorespiratory arrest, pulmo-
nary edema, or shock) occurred in 13.8% of the 
MINOCA patients and in 17.6% of the MIOCA 
group (p = 0.335). In-hospital mortality was non-
-significantly lower in MINOCA patients (0.9% vs. 
3.4%; p = 0.167).
At discharge, double antiplatelet treatment 
was prescribed in 62.0% of MINOCA patients, 
as compared with 99.7% of the MIOCA patients 
(p < 0.001). There were also differences in the 
prescription of beta-blockers (60.2% vs. 86.8%, 
p < 0.001), angiotensin convertase enzyme inhibi-
tors/angiotensin II receptor antagonists (59.3% vs. 
78.2%, p < 0.001), and statins (58.3% vs. 95.7%, 
p < 0.001). Anticoagulation prescription was 
higher in the MINOCA group (22.2% vs. 10.1%; 
p < 0.001). 
Predictors of MINOCA at admission
Six characteristics that could be determined 
at admission had independent association with 
MINOCA and can be used as early predictors: 
female gender, absence of diabetes, absence of to-
bacco use, tachycardia (100 bpm or above), troponin 
above 10 times 99-percentile (usual laboratory 
threshold), and the presence of a pro-inflammatory 
condition (autoimmune diseases, or active cancer, 
or AMI being a complication during hospitalization 
for another pathology). Details of the analysis are 
represented in Table 4.
Prognosis
Median follow-up was 17.3 ± 9.3 months. The 
time-to-event analysis is summarized in Figure 2. 
MACE occurred in 10.8% of the MINOCA group 
as compared with 10.7% in the MIOCA group (HR 
of 1.19, 95% CI 0.58–2.45; p = 0.645). Regarding 
individual components, cardiovascular mortality 
was non-significantly lower in the MINOCA group 
(2.8% vs. 5.1%; HR 0.54, 95% CI 0.12–2.36). Also, 
they had a non-significantly higher rate of TIA/ 
/stroke (3.0% vs. 0.8%; HR 2.89, CI, 0.52–16.13) 
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Table 2. Demographic profile, cardiovascular risk factors, proinflammatory conditions, and other  
comorbidities comparing both cohorts. 
MINOCA (n = 109) MIOCA (n = 412) p
Basal characteristics
Age [years] 64.6 ± 14.9 66.7 ± 13.5 0.171
Female gender 56/109 (51.4) 90/412 (21.8) < 0.001
Cardiovascular risk factors
Hypertension 67/109 (61.5) 256/412 (62.1) 0.830
Diabetes 26/109 (23.9) 146/412 (35.6) 0.020
Dyslipidemia 49/109 (45.2) 223/412 (54.1) 0.090
Tobacco use 44/109 (40.3) 270/412 (65.5) < 0.001
Pro-inflammatory conditions 38/109 (34.9) 58/412 (14.0) < 0.001
Active cancer 11/109 (10.1) 14/412 (3.4) 0.004
Autoimmune diseases 19/109 (17.4) 33/412 (8.0) 0.004
AMI while hospitalization for other pathology 8/109 (7.3) 10/412 (2.4) 0.13
Other comorbidities
Atrial fibrillation 16/109 (14.7) 30/412 (7.3) 0.016
Psychosocial disorders 25/109 (22.9) 44/412 (10.7) 0.001
Migraine 11/109 (10.1) 17/412 (4.1) 0.015
AMI — acute myocardial infarction; MINOCA — myocardial infarction with non-obstructive coronary arteries; MIOCA — myocardial infarction 
with obstructive coronary arteries
Table 3. Characteristics at admission and in-hospital complications.
MINOCA (n = 109) MIOCA (n = 412) P
At admission 
Heart rate [bpm] 89.2 ± 27.1 79.1 ± 17.7 < 0.001
Systolic arterial pressure [mmHg] 140.7 ± 28.0 143.7 ± 30.1
ST-segment elevation 26/109 (24.1) 166/412 (40.8) 0.001
ST-segment decrease or inversion of T wave 66/109 (61.1) 295/412 (72.7) 0.020
Laboratory 
Troponin T HS [ng/mL] 743.1 ± 1808.6 2856.2 ± 0 < 0.001
Hemoglobin [g/dL] 13.5 ± 2.1 14.2 ± 1.8 0.003
Creatinine [mg/dL] 1.1 ± 0.9 1.2 ± 1.1 0.467
Echocardiogram 
Left ventricular dysfunction 37/109 (33.8) 130/412 (31.5) 0.659
Severe left ventricular dysfunction 8/109 (7.4) 20/412 (4.5) 0.313
Moderate-severe valve disease 7/109 (6.4) 20/412 (4.8) 0.509
Pulmonary hypertension 5/109 (4.6) 27/412 (6.6) 0.436
In-hospital complications 15/109 (13.8) 72/412 (17.6) 0.335
Reinfarction 3/109 (2.8) 16/412 (3.9) 0.562
Major bleeding 2/109 (1.8) 13/412 (3.2) 0.453
Acute cerebrovascular accident 3/109 (2.8) 7/412 (1.7) 0.487
Cardio-respiratory arrest 0/109 (0.0) 15/412 (3.7) 0.042
Acute pulmonary edema 8/109 (7.3) 24/412 (5.9) 0.579
Cardiogenic shock 5/109 (4.6) 33/412 (8.1) 0.211
Mechanical complications 0/109 (0.0) 2/412 (0.5) 0.463
In-hospital mortality 1/109 (0.9) 14/412 (3.4) 0.167
Duration of hospitalization (days) 8.89 ± 13.1 6.91 ± 6.0 0.025
Severe left ventricle dysfunction is defined as ejection fraction < 30%; MINOCA — myocardial infarction with non-obstructive coronary arteries; 
MIOCA — myocardial infarction with obstructive coronary arteries 
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and re-infarction (5.9% vs. 4.7%; HR 1.61, 95% CI 
0.60–4.29). Cardiovascular re-admission rates were 
higher in the MINOCA group: 19.8% as compared 
with 13.9% in the MIOCA group (HR 1.85, 95% CI 
1.06–3.21; p = 0.030). 
Death from any cause occurred in 6.9% of 
MINOCA patients as compared with 9.3% in the 
MIOCA group (HR 0.93, 95% CI 0.38–2.29). The 
proportion of all-cause re-admission rates tended to 
be higher in the MINOCA group: 33.7% vs. 32.7% 
(HR 1.45, 95% CI 0.94–2.25; p = 0.097). Details 
regarding these analyses are provided in Table 5.
At the 1-year interview, 1.0% of MINOCA pa-
tients referred stable angina compared with 2.4% of 
the MIOCA patients (p = 0.337); at that moment, 
dyspnea worse than New York Heart Association II 
was present in 6.1% of the MINOCA vs. 9.6% of 
the MIOCA group (p = 0.268).
Discussion
The impact of MINOCA on daily clinical prac-
tice is high, representing 16.9% of all AMI in 
which coronariography is performed. This propor-
tion is slightly higher than previously described 
[2, 3, 10–12] and may be related to the use of 
new ultra-sensitive troponin assay, even though 
cases of myocardial injury were not included. Im-
proved early screening techniques and increased 
awareness are leading to increased MINOCA 
diagnoses [23].
This job is in line with previous studies by 
checking that patients with MINOCA are more 
frequently women [24] and have a better cardiovas-
cular risk profile compared with MIOCA patients 
[3, 6, 7, 10, 12]. An interesting new point here is 
that the prevalence of atrial fibrillation is higher in 
Figure 2. Kaplan-Meyer curves comparing both cohorts: myocardial infarction with non-obstructive coronary arteries 
(MINOCA) and myocardial infarction with obstructive coronary arteries (MIOCA); A. Major adverse cardiovascular 
events (cardiovascular death, transient ischemic attack/stroke, or re-infarction); B. All-cause mortality; C. Cardiovas-
cular re-admissions; HR —hazard ratio adjusted by age and cardiovascular risk factors; CI — confidence interval. 
Table 4. Early predictors of myocardial infarction with non-obstructive coronary arteries by multivariable 
analysis.
Odds ratio 95% CI p
Female gender 2.60 1.50–4.51 0.001
Tobacco use 0.49 0.29–0.83 0.008
Diabetes 0.44 0.25–0.76 0.004
Pro-inflammatory conditions 2.32 1.33–4.05 0.003
Tachycardia at admission 2.32 1.27-–4.24 0.006
Troponin T peak > 10×p99 2.53 1.35–4.73 0.004
CI — confidence interval; pro-inflammatory conditions — active cancer, autoimmune diseases or acute myocardial infarction during other  
pathology hospitalization; 10×p99 — 10 times 99th percentile
0.0
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MINOCA, a fact that could be related to coronary 
emboli as the physiopathological explanation in 
some cases.
Also, psychiatric diseases, migraine, and 
pro-inflammatory conditions are more frequent 
in the MINOCA group than in MIOCA. Previous 
studies proposed a connection between psychiat-
ric diseases and MINOCA [25], specifically with 
takotsubo syndrome [8]. This was also checked 
in a sub-analysis of our group in which, even after 
excluding takotsubo syndrome patients from the 
analysis, MINOCA and psychosocial disorders 
remained associated [9]. Different mechanisms 
could explain this association: the most reason-
able of which is the impact of emotional stress in 
sympathetic regulation [26], being catecholamine 
levels a fundamental player in the endothelial func-
tion regulation [27]. Direct catecholamine toxicity 
on cardiomyocytes has also been proposed [28]. 
Nociceptive mechanisms of migraine are thought 
to be in relation with vascular tone dysregulation 
[29], one of the feasible mechanisms underlying 
MINOCA.
A higher presence of pro-inflammatory condi-
tions in MINOCA has recently been described [7] 
and points in the direction of new evidence about 
the interrelation between the immune system and 
ischemic heart disease. Some interesting studies 
have also been published in this field, like the 
CANTOS trial [30], reflecting the impact of im-
munomodulator therapies in cardiovascular risk; or 
the relation between influenza infection and AMI 
[31]. As for MINOCA, a hypersensitivity-associated 
AMI has also been described, known as Kounis 
syndrome [32].
It has been postulated that MINOCA patients 
have a better prognosis than MIOCA patients [3]. 
However, given the heterogeneity of the analyzed 
groups in previous studies, there are significant 
differences regarding the prognosis (between 
3% and 8% of 1-year mortality) [3, 6, 10–12, 33]. 
One of the latest works [25] described a 1-year 
mortality of 4.7% while in other specific types of 
presentation (ST-segment elevation MINOCA) 
1-year mortality was 7% [10]. In Spain [6] there 
was lower mortality at 3-year follow-up in patients 
with non-ST-segment elevation AMI and non-
significant stenosis compared with those with 
significant stenosis, while in a more recent work 
[12] the described mortality was similar to those 
patients with one-vessel disease. Considerable 
differences in the inclusion criteria of these works 
should be taken into account.
This prospective study based on the stand-
ards of MINOCA definition shows that MINOCA 
prognosis could be worse than was previously 
thought. Despite a lower CVFR charge, MINOCA 
did not differ from MIOCA in terms of MACE 
events and had a higher number of cardiovascu-
lar re-hospitalizations. There was an excess of 
mortality in the MIOCA group, but, conversely, 
MINOCA patients had more re-infarction and 
TIA/stroke during follow-up. MINOCA may en-
compass milder mechanisms that confer a better 
prognosis, but could also lead to misdiagnosis in 
the index episode.
The daily importance of MINOCA is high, 
not only because of its incidence, but also for all 
the complex studies it requires for its correct 
characterization in order to adjust the proper treat-
ment (intravascular imaging, magnetic resonance) 
[34, 35]. This causes a longer hospitalization and, 
consequently, an increment in the economic costs. 
Studies like this one would help to know better 
Table 5. Main findings at 12-month follow-up survival analysis adjusted by age and cardiovascular risk 
factors (hypertension, dyslipidemia, diabetes, and tobacco).
MINOCA MIOCA HR 95% CI P
MACE 10.8% 10.7% 1.19 0.58–2.45 0.645
CV re-admission 19.8% 13.9% 1.85 1.06–3.21 0.030
CV mortality 2.8% 5.1% 0.54 0.12–2.36 0.410
Re-infarction 5.9% 4.7% 1.61 0.60–4.29 0.341
TIA or stroke 3.0% 0.8% 2.89 0.52–16.13 0.226
Total mortality 6.9% 9.3% 0.93 0.381–2.29 0.880
Re-admission 33.7% 32.7% 1.45 0.94–2.25 0.097
CI — confidence interval; CV — cardiovascular; HR — hazard ratio; MACE — major adverse cardiovascular events (infarction, TIA/stroke or 
CV death); MINOCA — myocardial infarction with non-obstructive coronary arteries; MIOCA — myocardial infarction with obstructive coronary 
arteries; TIA — transient ischemic attack
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the role of the working diangnosis of MINOCA in 
the future as well as helping to reveal independent 
predictors in these patients. 
Limitations of the study
Apart from the inherent problems of an ob-
servational single-center study, this work has 
other limitations that must be outlined to provide 
a correct interpretation of the results: (1) It was 
conducted in a center with a modest recruit-
ment capacity, so the recruitment period had to 
be prolonged for three years. This could lead 
to a reduction in the power of some analyses; 
(2) We had some financial limitations for perform-
ing exhaustive intravascular imaging. That affects 
the characterization of MINOCA patients whose 
mechanism was the transient complication of the 
atheroma plaque [35], and some of them could have 
been erroneously classified as an unknown mecha-
nism; (3) The same argument applies to magnetic 
resonance (performed in only 34.3% of MINOCA 
patients). Despite this, economic restrictions are 
unfortunately a common factor nowadays, and this 
can reflect the daily clinical practice for many of 
hospitals. This improves the applicability of the re-
sults presented. Including all consecutive MINOCA 
patients may mitigate in part this limitation.
Conclusions  
MINOCA represents a considerable proportion 
of all AMIs. Its clinical presentation is very similar 
to MIOCA, so it reinforces the idea of considering it 
as a “working diagnosis”. These results are in agree-
ment with most previous reports. However, mid-term 
prognosis may be worse than previously thought. 
Patients with MINOCA have lower charge of 
traditional risk factors, but psychosocial disorders, 
pro-inflammatory conditions, atrial fibrillation, and 
migraine are more frequent among them. This 
study complements the study of MINOCA and 
provides some new data in this field that could 
improve the future management of these patients.
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